89bio, Inc.
ETNBDelisted Oct 30, 2025- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785173
89bio, Inc. was delisted on Oct 30, 2025; its insiders filed their last Form 4 on Nov 3, 2025; 198 institutions reported holding it in 13F filings for Q3 2025, worth $2.27B in total; no superinvestor held it.
13F holders, Q4 2022
Institutional positions in 89bio, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 106
- +21 vs. Q3 2022
- Shares held
- 46.3M
- +7.45M (+19.2%) vs. Q3 2022
- Total value
- $589.5M
- +$364.5M (+162.0%) vs. Q3 2022
- New holders
- 39
- 34 more added
- Sold out
- 18
- 19 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ETNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 2 | $1.11M |
| Q3 2025 | 198 | $2.27B |
| Q2 2025 | 185 | $1.58B |
| Q1 2025 | 187 | $1.14B |
| Q4 2024 | 156 | $948.7M |
| Q3 2024 | 144 | $773.8M |
| Q2 2024 | 145 | $828.4M |
| Q1 2024 | 150 | $1.14B |
| Q4 2023 | 153 | $1.05B |
| Q3 2023 | 160 | $1.11B |
| Q2 2023 | 157 | $1.46B |
| Q1 2023 | 147 | $1.08B |
| Q4 2022 | 106 | $589.5M |
| Q3 2022 | 86 | $227.3M |
| Q2 2022 | 70 | $104.6M |
| Q1 2022 | 69 | $64.3M |
| Q4 2021 | 50 | $226.1M |
| Q3 2021 | 48 | $339.4M |
| Q2 2021 | 49 | $315.2M |
| Q1 2021 | 67 | $400.6M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding 89bio, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Holocene Advisors, LP | 1,900,532 | $24.2M | 0.15% | +1,900,532 | New |
| Adage Capital Partners GP, L.L.C. | 1,987,592 | $25.3M | 0.06% | −262,408−11.7% | Reduced |
| Cormorant Asset Management, LP | 2,550,000 | $32.5M | 2.18% | +2,550,000 | New |
| OrbiMed Advisors LLC | 3,658,869 | $46.6M | 0.89% | 00.0% | Unchanged |
| Deep Track Capital, LP | 3,850,000 | $49.0M | 2.14% | +1,214,000+46.1% | Added |
| Ra Capital Management, L.P. | 8,955,410 | $114.0M | 2.31% | +1,172,741+15.1% | Added |
| BVF Inc | 0 | $0 | 0.00% | −3,143,682−100.0% | Sold out |
| Rubric Capital Management LP | 0 | $0 | 0.00% | −989,388−100.0% | Sold out |
| Great Point Partners LLC | 0 | $0 | 0.00% | −955,000−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −250,000−100.0% | Sold out |
| CSS LLC | 0 | $0 | 0.00% | −111,693−100.0% | Sold out |
| UBS Oconnor LLC | 0 | $0 | 0.00% | −92,034−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −87,164−100.0% | Sold out |
| Occudo Quantitative Strategies LP | 0 | $0 | 0.00% | −40,126−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −32,883−100.0% | Sold out |
| Glenmede Trust Co NA | 0 | $0 | 0.00% | −32,338−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −30,648−100.0% | Sold out |
| Maven Securities LTD | 0 | $0 | 0.00% | −20,000−100.0% | Sold out |
| Connor, Clark & Lunn Investment Management Ltd. | 0 | $0 | 0.00% | −18,165−100.0% | Sold out |
| Penn Mutual Asset Management, LLC | 0 | $0 | 0.00% | −10,292−100.0% | Sold out |
| Captrust Financial Advisors | 0 | $0 | 0.00% | −10,294−100.0% | Sold out |
| Aquatic Capital Management LLC | 0 | $0 | 0.00% | −9,100−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −187−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −170−100.0% | Sold out |
| Empery Asset Management, LP | – | – | – | – | Not filed |